Short half-life hypnotics preserve physical fitness and altitude tolerance during Military mountainous training

Military Medicine

Volumn 174, Issue 9, 2009, Pages 964-970

  Jouanin, Jean Claude ^a   Dussault, Caroline ^a   Beers, Pascal Van ^a   Piérard, Christophe ^a   Beaumont, Maurice ^b  

^a Department of Aerospace Physiology   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; ZALEPLON; ZOLPIDEM;

ADULT; ALTITUDE DISEASE; ANALYSIS OF VARIANCE; ARTICLE; FITNESS; HALF LIFE TIME; HEART RATE; HUMAN; MALE; MOUNTAINEERING; PHYSIOLOGY; SOLDIER; STATISTICAL MODEL; SWITZERLAND;

ACETAMIDES; ALTITUDE SICKNESS; ANALYSIS OF VARIANCE; HALF-LIFE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; LINEAR MODELS; MALE; MILITARY PERSONNEL; MOUNTAINEERING; PHYSICAL FITNESS; PYRIDINES; PYRIMIDINES; SWITZERLAND; YOUNG ADULT;

EID: 70350743137     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-03-1708     Document Type: Article

References (33)

1. Ainslie PN, Kolb JC, Die K, Poulin MJ: Effect of five nights of normobaric hypoxia on cardiovascular responses to acute isocapnic hypoxia in humans: relationship to ventilator}' chemosensitivity. Ergonomics 2005;48:1523-34.
2. Blabcr AP, Hartley T, Pretorius PJ: Effect of acute exposure to 3, 660 m altitude on orthostatic response and tolerance. J Appl Physiol 2002;95:591-601.
3. Kanai M, Nishihara F, Shiga T, Shimada H, Saito S: Alterations in autonomic nervous control of heart rate among tourists at 2, 700 and 3, 700 m above sea level. Wilderness Environ Med 2001;12:8-12.
4. Hughson RL, Yamamoto Y, Mc Cullough RE, Sutton JR, Reeves JT: Sympathetic and parasympathetic indicators of heart rate control at altitude studied by spectral analysis. J Appl Physiol 1994; 77: 2537-42.
5. Perini R, Milesi S, Biancardi L, Veicsteinas A: Effects of high altitude acclimatization on heart rate variability in resting humans. Eur J Appl Physiol 1995; 73: 521-8.
6. Sevre K, Bendz B, Hanko E, et al: Reduced autonomic activity during stepwise exposure to high altitude. Acta Physiol Scand 2001; 173: 409-17.
7. Cornolo J, Brugniaux JV, Macarlupu JL, Privat C, Leon-Velarde F, Richalet JP: Autonomic adaptations in Andean trained participants to a 4220-m altitude marathon. Med Sci Sports Exerc 2005;37:2148-53.
8. Barak Y, David D, Keselbrener L, Askelrod S: Autonomic response to hypobaric hypoxia assessed by time-dependent frequency decomposition of heart rate. Aviat Space Environ Med 2001; 72: 992-1000.
9. Hainsworth R, Drinkhill MJ, Rivera-Chira M: The autonomic nervous system at high altitude. Clin Auton Res 2007; 17: 13-9.
10. Pigman EC, Karakla DW: Acute Mountain sickness at immediate altitude: military mountainous training. Am J Emerg Med 1990; 8: 7-10.
11. Basnyat B, Murdoch DR: High-altitude illness. Lancet 2003; 361: 1967-74.
12. Lanfranchi PA, Colombo R, Cremona G, et al: Autonomic cardiac regulation in subjects with acute mountain sickness. Am J Physiol Heart Circ Physiol 2005: 289:112364-72.
13. Beaumont M, Baléjal D, Coste O, et al: Effects of Zolpidem and Zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4, 000 m. Neuropsychobiology 2004;49:154-62.
14. Beaumont M, Batéjat D, Piérard C, et al: Zaleplon and Zolpidem objectively alleviate sleep disturbances in mountaineers at a 3, 613 m altitude. Sleep 2007; 30: 1527-33.
15. Dubowilz G: Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial. BMJ 1998;316:587-9.
16. Nicholson AN, Smith PA, Stone BM, Bradwell AR, Coote JH: Altitude insomnia: studies during an expedition to the Himalayas. Sleep 1988; 11: 354-61.
17. Nickol AH, Leverment J, Richards P, et al: Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res 2006;15:445-54.
18. Paul MA, Gray G, Kenny G, Pigeau R: Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003;74:1263-70.
19. Yamamoto K, Miyachi M, Saitoh T, Yoshioka A, Onodera S: Effects of endurance training on resting and post-exercise cardiac autonomic control. Med Sci Sports Exerc 2000; 33: 1496-502.
20. Jouanin JC, Dussault C, Peres M, Satabin P, Pierard C, Guezennec CY: Analysis of heart rate variability after a ranger training course. Mil Med 2004; 169: 583-587.
21. Anonymous: The Lake Louise consensus on the definition and quantification of altitude illness. In: Hypoxia and Mountain Medicine, pp 327-330. Edited by Sutton J, Coates G, Houston C, Burlington, Quenn City Press, 1992.
22. Task Eorce of European society of cardiology and the North American society of pacing and electrophysiology: Heart rate variability. Circulation 1996; 5:1043-1065.
23. Eckberg DL: Physiological basis for human autonomic rhythms. Ann Med 2000; 32: 341-9.
24. Kolb JC, Ainslie PN, Ide K, Poulin MJ: Effects of five consecutive nocturnal hypoxic exposures on the cerebrovascular responses to acute hypoxia and hypercapnia in humans. J Appl Physiol 2004; 96: 1745-54.
25. Yang CH, Lai CWL, Lai HY, Kuo TBJ: Relationship between electroencephalogram slow-wave magnitude and heart-rate variability during sleep in humans. Neurosci Lett 2003; 329: 213-6.
26. Saito S, Tanobe K, Yamada M, Nishihara E: Relationship between arterial oxygen saturation and heart rate variability at high altitudes. Am J Emerg Med 2005; 23: 8-12.
27. Bernardi L: Interval hypoxic training. In: From Genes to the Bedside, pp 377-399. Edited by Roach RC, et al. New York, Kluwer Academic/Plenum Publishers, 2001.
28. Farinelli CO, Kayser B, Binzoni T, Cerretelli P, Girardier L: Autonomic nervous control of heart rate at altitude (5, 050 m). Eur J Appl Physiol 1994;69:502-7.
29. Richalet JP, Kéromès A, Carillion, Mehdioui H, Larmignat P, Rathat C: Cardiac response to hypoxia and susceptibility to mountain sickness. Arch Mal Coeur Vaiss 1989;82:49-54.
30. Hackett PH, Roach RC: High-altitude illness. N Engl J Med 2001; 345: 107-14.
31. Beidelman BA, Muza SR, Fulco CS, et al: Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Clin Sci (Lond) 2004; 106: 321-8.
32. Katayama K, Sato Y, Ishida K, Mori S, Miyamura M: The effects of intermittent exposure to hypoxia during endurance exercise training on the ventilatory responses to hypoxia and hypercapnia in humans. Eur J Appl Physiol 1998;78:189-94.
33. Bartsch P, Maggiorini M, Schobersberger W, et al: Enhanced exerciseinduced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol 1991; 71: 136-43.